These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11311295)

  • 1. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
    Meglic B; Graus F; Grad A
    J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K; Saltzman JR; Carr-Locke DL
    MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
    J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
    Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
    Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report].
    Goto A; Kusumi M; Wakutani Y; Nakaso K; Kowa H; Nakashima K
    Rinsho Shinkeigaku; 2006 Feb; 46(2):144-7. PubMed ID: 16619840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M; Tanaka K; Onodera O; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
    Yshii L; Bost C; Liblau R
    Front Immunol; 2020; 11():991. PubMed ID: 32655545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
    Tanaka M; Tanaka K
    Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
    Nardelli E; Currò-Dossi B; Rizzuto N; Graus F
    Clin Neurol Neurosurg; 1995 Feb; 97(1):89-94. PubMed ID: 7540522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
    Bradwell AR
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
    Storstein A; Krossnes BK; Vedeler CA
    Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
    Panja D; Vedeler CA; Schubert M
    Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
    Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A
    J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
    J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.